The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Deutsche Bank proposes new members for supervisory board ahead of shareholder meeting
Deutsche Bank has proposed Kirsty Roth, chief operations and technology officer at Thomson Reuters, and Klaus Moosmayer, chief ethics, risk & compliance officer at Novartis, to join its supervisory board at the annual shareholder meeting on May 22. They will replace Theodor Weimer and Dagmar Valcarcel, whose terms are expiring. Additionally, CEO Christian Sewing's contract has been extended amid a management revamp that will see the departure of the finance chief and another top executive.
Deutsche Bank proposes Kirsty Roth and Klaus Moosmayer for supervisory board
Deutsche Bank has proposed Kirsty Roth and Klaus Moosmayer for its supervisory board, with a vote scheduled for the annual shareholder meeting on May 22. They will replace Theodor Weimer and Dagmar Valcarcel, whose terms are expiring. Additionally, CEO Christian Sewing's contract has been extended amid a management overhaul, which will see the departure of the finance chief and another executive.
Swiss National Bank reduces forex interventions to 1.2 billion francs in 2024
The Swiss National Bank purchased foreign currency worth 1.2 billion Swiss francs ($1.36 billion) in 2024, significantly decreasing its market interventions after successfully controlling inflation. This contrasts sharply with the 132.9 billion Swiss francs sold in 2023 to strengthen the franc against rising import prices.
ubs faces uncertainty over capital requirements amid regulatory debate in switzerland
UBS has expressed concerns over the "ill-informed" public debate in Switzerland regarding its size and activities, which is creating uncertainty as the country considers new banking regulations. Following its acquisition of Credit Suisse, UBS is facing stricter capital requirements, despite already meeting high standards for globally systemically important banks. The bank supports measures for individual executive accountability and a permanent safety net for systemically important institutions, while awaiting further details on capital requirements from the Swiss government.
ubs highlights uncertainty from public debate on banking regulations in switzerland
UBS has expressed concerns over an "ill-informed" public debate in Switzerland regarding the risks associated with its business and size, which is creating uncertainty ahead of 2025. The bank, facing new regulations after acquiring Credit Suisse, is already meeting high capital requirements but awaits further details from the Swiss government on future capital needs. UBS supports measures for executive accountability and a public liquidity backstop for systemically important banks.
ubs highlights uncertainty amid regulatory debate following credit suisse acquisition
UBS has expressed concerns over the "ill-informed" public debate in Switzerland regarding its business risks and size, which is creating uncertainty as the country prepares to regulate its largest bank. Following its acquisition of Credit Suisse, UBS is facing stricter capital requirements, despite already meeting high standards for global systemically important banks. The bank supports measures for executive accountability and a permanent liquidity backstop for systemically important institutions, while awaiting further details on capital requirements from the Swiss government.
ubs addresses public concerns over risks and size in annual report
UBS Group has expressed concerns that the public debate regarding its size and potential risks has led to uncertainties as 2025 approaches. The bank emphasized that its low-risk business model and high asset quality distinguish it from the former Credit Suisse, making UBS a more secure financial institution.
ubs addresses public concerns over risks and size ahead of 2025
UBS Group, Switzerland's largest bank, has expressed concern that the public debate surrounding its size and associated risks is often misinformed, leading to uncertainty as it approaches 2025. The bank emphasized that its low-risk business model and high asset quality distinguish it from the former Credit Suisse, making UBS a safer financial institution.
Novartis to close MorphoSys sites affecting 330 jobs by 2025
Novartis is closing MorphoSys sites in Germany and the United States, impacting 330 jobs as part of a strategic evaluation of its organizational structure following the acquisition of MorphoSys earlier this year. The company plans to exit the Munich and Boston locations by the end of 2025 and is committed to supporting affected employees.
Novartis to close Morphosys affecting 330 jobs by end of 2025
Novartis is set to close the German biotech company Morphosys, resulting in the loss of 330 jobs. The decision, announced in November 2024, involves shutting down Morphosys sites in Germany and the U.S. by the end of 2025, with all portfolio activities being integrated into Novartis.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.